![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cyrib | Mouse | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1354500 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CYRIB mRNA | CTD | PMID:22079256 | Cyrib | Mouse | 1,1-dichloroethene | increases expression | EXP | | 6480464 | vinylidene chloride results in increased expression of CYRIB mRNA | CTD | PMID:26682919 | Cyrib | Mouse | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of CYRIB mRNA | CTD | PMID:22206623 | Cyrib | Mouse | 1-naphthyl isothiocyanate | increases expression | ISO | RGD:1307697 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CYRIB mRNA | CTD | PMID:25380136 | Cyrib | Mouse | 17beta-estradiol | decreases expression | ISO | RGD:1354500 | 6480464 | Estradiol results in decreased expression of CYRIB mRNA | CTD | PMID:19167446 | Cyrib | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1307697 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYRIB mRNA | CTD | PMID:32109520 | Cyrib | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1307697 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYRIB mRNA | CTD | PMID:34747641 | Cyrib | Mouse | 2-bromohexadecanoic acid | multiple interactions | ISO | RGD:1354500 | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... | CTD | PMID:38195004 | Cyrib | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1354500 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Cyrib | Mouse | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1307697 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of CYRIB mRNA | CTD | PMID:25380136 | Cyrib | Mouse | 4,4'-sulfonyldiphenol | decreases expression | EXP | | 6480464 | bisphenol S results in decreased expression of CYRIB mRNA | CTD | PMID:39298647 | Cyrib | Mouse | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1354500 | 6480464 | bisphenol S results in increased expression of CYRIB protein | CTD | PMID:34186270 | Cyrib | Mouse | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of CYRIB mRNA | CTD | PMID:28973697 | Cyrib | Mouse | acetamide | increases expression | ISO | RGD:1307697 | 6480464 | acetamide results in increased expression of CYRIB mRNA | CTD | PMID:31881176 | Cyrib | Mouse | Aflatoxin B2 alpha | increases methylation | ISO | RGD:1354500 | 6480464 | aflatoxin B2 results in increased methylation of CYRIB promoter | CTD | PMID:30157460 | Cyrib | Mouse | all-trans-retinoic acid | decreases expression | ISO | RGD:1354500 | 6480464 | Tretinoin results in decreased expression of CYRIB mRNA | CTD | PMID:23724009 | Cyrib | Mouse | antirheumatic drug | decreases expression | ISO | RGD:1354500 | 6480464 | Antirheumatic Agents results in decreased expression of CYRIB mRNA | CTD | PMID:24449571 | Cyrib | Mouse | arsane | affects methylation | ISO | RGD:1354500 | 6480464 | Arsenic affects the methylation of CYRIB gene | CTD | PMID:25304211 | Cyrib | Mouse | arsenic atom | affects methylation | ISO | RGD:1354500 | 6480464 | Arsenic affects the methylation of CYRIB gene | CTD | PMID:25304211 | Cyrib | Mouse | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:1354500 | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CYRIB mRNA | CTD | PMID:19150397 | Cyrib | Mouse | benzo[e]pyrene | increases methylation | ISO | RGD:1354500 | 6480464 | benzo(e)pyrene results in increased methylation of CYRIB promoter | CTD | PMID:30157460 | Cyrib | Mouse | bisphenol A | decreases expression | ISO | RGD:1354500 | 6480464 | bisphenol A results in decreased expression of CYRIB mRNA | CTD | PMID:29275510|PMID:33670352 | Cyrib | Mouse | bisphenol A | increases expression | ISO | RGD:1354500 | 6480464 | bisphenol A results in increased expression of CYRIB protein | CTD | PMID:34186270 | Cyrib | Mouse | bisphenol A | increases expression | ISO | RGD:1307697 | 6480464 | bisphenol A results in increased expression of CYRIB mRNA | CTD | PMID:25181051 | Cyrib | Mouse | bisphenol AF | increases expression | ISO | RGD:1354500 | 6480464 | bisphenol AF results in increased expression of CYRIB protein | CTD | PMID:34186270 | Cyrib | Mouse | Bisphenol B | increases expression | ISO | RGD:1354500 | 6480464 | bisphenol B results in increased expression of CYRIB protein | CTD | PMID:34186270 | Cyrib | Mouse | bisphenol F | multiple interactions | ISO | RGD:1354500 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Cyrib | Mouse | C60 fullerene | decreases expression | ISO | RGD:1307697 | 6480464 | fullerene C60 results in decreased expression of CYRIB mRNA | CTD | PMID:19167457 | Cyrib | Mouse | cadmium atom | multiple interactions | ISO | RGD:1354500 | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... | CTD | PMID:38195004 | Cyrib | Mouse | cadmium dichloride | multiple interactions | ISO | RGD:1354500 | 6480464 | 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in more ... | CTD | PMID:38195004 | Cyrib | Mouse | cannabidiol | decreases expression | EXP | | 6480464 | Cannabidiol results in decreased expression of CYRIB mRNA | CTD | PMID:21542829 | Cyrib | Mouse | carbon nanotube | affects expression | EXP | | 6480464 | Nanotubes, Carbon affects the expression of CYRIB protein | CTD | PMID:21135415 | Cyrib | Mouse | coumestrol | decreases expression | ISO | RGD:1354500 | 6480464 | Coumestrol results in decreased expression of CYRIB mRNA | CTD | PMID:19167446 | Cyrib | Mouse | coumestrol | multiple interactions | ISO | RGD:1354500 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYRIB mRNA | CTD | PMID:19167446 | Cyrib | Mouse | DDE | increases expression | ISO | RGD:1354500 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of CYRIB mRNA | CTD | PMID:38568856 | Cyrib | Mouse | dexamethasone | multiple interactions | ISO | RGD:1354500 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Cyrib | Mouse | dibutyl phthalate | decreases expression | ISO | RGD:1307697 | 6480464 | Dibutyl Phthalate results in decreased expression of CYRIB mRNA | CTD | PMID:21266533 | Cyrib | Mouse | dicrotophos | decreases expression | ISO | RGD:1354500 | 6480464 | dicrotophos results in decreased expression of CYRIB mRNA | CTD | PMID:28302478 | Cyrib | Mouse | Enterolactone | multiple interactions | ISO | RGD:1354500 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYRIB mRNA | CTD | PMID:19167446 | Cyrib | Mouse | enzyme inhibitor | multiple interactions | ISO | RGD:1354500 | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation more ... | CTD | PMID:23301498 | Cyrib | Mouse | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of CYRIB mRNA | CTD | PMID:30319688 | Cyrib | Mouse | hydroquinone O-beta-D-glucopyranoside | increases expression | ISO | RGD:1354500 | 6480464 | Arbutin results in increased expression of CYRIB mRNA | CTD | PMID:17103032 | Cyrib | Mouse | indometacin | multiple interactions | ISO | RGD:1354500 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Cyrib | Mouse | ivermectin | decreases expression | ISO | RGD:1354500 | 6480464 | Ivermectin results in decreased expression of CYRIB protein | CTD | PMID:32959892 | Cyrib | Mouse | methapyrilene | increases methylation | ISO | RGD:1354500 | 6480464 | Methapyrilene results in increased methylation of CYRIB promoter | CTD | PMID:30157460 | Cyrib | Mouse | methylmercury chloride | decreases expression | ISO | RGD:1354500 | 6480464 | methylmercuric chloride results in decreased expression of CYRIB mRNA | CTD | PMID:28001369 | Cyrib | Mouse | N-nitrosodimethylamine | increases expression | ISO | RGD:1307697 | 6480464 | Dimethylnitrosamine results in increased expression of CYRIB mRNA | CTD | PMID:25380136 | Cyrib | Mouse | nickel atom | increases expression | ISO | RGD:1354500 | 6480464 | Nickel results in increased expression of CYRIB mRNA | CTD | PMID:24768652|PMID:25583101 | Cyrib | Mouse | oxaliplatin | multiple interactions | ISO | RGD:1307697 | 6480464 | [Oxaliplatin co-treated with Topotecan] results in decreased expression of CYRIB mRNA | CTD | PMID:25729387 | Cyrib | Mouse | potassium chromate | multiple interactions | ISO | RGD:1354500 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CYRIB mRNA | CTD | PMID:22079256 | Cyrib | Mouse | potassium chromate | decreases expression | ISO | RGD:1354500 | 6480464 | potassium chromate(VI) results in decreased expression of CYRIB mRNA | CTD | PMID:22079256 | Cyrib | Mouse | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYRIB mRNA | CTD | PMID:21641980 | Cyrib | Mouse | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of CYRIB mRNA | CTD | PMID:23557971 | Cyrib | Mouse | titanium dioxide | increases methylation | EXP | | 6480464 | titanium dioxide results in increased methylation of FAM49B gene | CTD | PMID:35295148 | Cyrib | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of FAM49B gene | CTD | PMID:35295148 | Cyrib | Mouse | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of CYRIB mRNA | CTD | PMID:29264374 | Cyrib | Mouse | topotecan | multiple interactions | ISO | RGD:1307697 | 6480464 | [Oxaliplatin co-treated with Topotecan] results in decreased expression of CYRIB mRNA | CTD | PMID:25729387 | Cyrib | Mouse | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of CYRIB mRNA | CTD | PMID:33045310 | Cyrib | Mouse | valproic acid | decreases methylation | ISO | RGD:1354500 | 6480464 | Valproic Acid results in decreased methylation of CYRIB gene | CTD | PMID:29154799 | Cyrib | Mouse | valproic acid | increases expression | ISO | RGD:1354500 | 6480464 | Valproic Acid results in increased expression of CYRIB mRNA | CTD | PMID:19101580 | Cyrib | Mouse | vinclozolin | decreases expression | ISO | RGD:1307697 | 6480464 | vinclozolin results in decreased expression of CYRIB mRNA | CTD | PMID:22570695 | |